glp-1 and dpp-4 inhibitors Role of Dipeptidyl Peptidase 4 in Antidiabetic Treatment Prescribing pearls: A guide to

A growing body of large-scale cardiovascular outcome trials (e.g., LEADER [35], SUSTAIN-6 [36], REWIND [37]) have demonstrated that specific GLP-1 RAs significantly reduce the risk of major adverse cardiovascular events, including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke

Who should consider using this peptide blend

Blood 120 , 24052411 (2012)

If you have concerns about blood clots whilst taking Mounjaro, it is essential to discuss these with your GP or diabetes specialist, who can assess your individual risk factors and provide personalised advice

How to Access GLP-1 Therapy Safely in the U.S